Translation initiation of leaderless and polycistronic transcripts in mammalian mitochondria
Published version
Peer-reviewed
Repository URI
Repository DOI
Type
Change log
Authors
Abstract
The synthesis of mitochondrial OXPHOS complexes is central to cellular metabolism, yet many molecular details of mitochondrial translation remain elusive. It has been commonly held view that translation initiation in human mitochondria proceeded in a manner similar to bacterial systems, with the mitoribosomal small subunit bound to the initiation factors, mtIF2 and mtIF3, along with initiator tRNA and an mRNA. However, unlike in bacteria, most human mitochondrial mRNAs lack 5′ leader sequences that can mediate small subunit binding, raising the question of how leaderless mRNAs are recognized by mitoribosomes. By using novel in vitro mitochondrial translation initiation assays, alongside biochemical and genetic characterization of cellular knockouts of mitochondrial translation factors, we describe unique features of translation initiation in human mitochondria. We show that in vitro, leaderless mRNA transcripts can be loaded directly onto assembled 55S mitoribosomes, but not onto the mitoribosomal small subunit (28S), in a manner that requires initiator fMet-tRNAMet binding. In addition, we demonstrate that in human cells and in vitro, mtIF3 activity is not required for translation of leaderless mitochondrial transcripts but is essential for translation of ATP6 in the case of the bicistronic ATP8/ATP6 transcript. Furthermore, we show that mtIF2 is indispensable for mitochondrial protein synthesis. Our results demonstrate an important evolutionary divergence of the mitochondrial translation system and further our fundamental understanding of a process central to eukaryotic metabolism.
Description
Funder: Karolinska Institutet; DOI: https://doi.org/10.13039/501100004047
Funder: International Helmholtz Research School of Biophysics and Soft Matter
Keywords
Journal Title
Conference Name
Journal ISSN
1362-4962
Volume Title
Publisher
Publisher DOI
Sponsorship
Knut and Alice Wallenberg Foundation (WAF 2017)
Wellcome Trust (106207)
European Research Council (646891)
NIH (1R01GM127374)